With a trade war hanging in the air over two national capitals, Sen. Marco Rubio (R-Fla.) has introduced a bill that would ratchet up the pressure on Beijing regarding products included in the Made in China 2025 program. The new bill, dubbed the Fair Trade with China Enforcement Act of 2018, would impose restrictions on China's ability to invest in companies across a range of industries, including biologics and "advanced medical equipment," and would prohibit the export to China of any intellectual property (IP) for artificial intelligence and biotechnology, thus applying further pressure on Beijing to tamp down on what many people believe is the nation's rampant intellectual property theft.